BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36853489)

  • 41. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.
    Mowatt G; Scotland G; Boachie C; Cruickshank M; Ford JA; Fraser C; Kurban L; Lam TB; Padhani AR; Royle J; Scheenen TW; Tassie E
    Health Technol Assess; 2013 May; 17(20):vii-xix, 1-281. PubMed ID: 23697373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
    Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
    Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging modalities in high-grade gliomas: pseudoprogression, recurrence, or necrosis?
    Caroline I; Rosenthal MA
    J Clin Neurosci; 2012 May; 19(5):633-7. PubMed ID: 22321359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [
    Rani N; Singh B; Kumar N; Singh P; Hazari PP; Vyas S; Hooda M; Chitkara A; Shekhawat AS; Gupta SK; Radotra BD; Mishra AK
    Cancer Biother Radiopharm; 2021 Sep; 36(7):568-578. PubMed ID: 32644819
    [No Abstract]   [Full Text] [Related]  

  • 45. The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI.
    Santo G; Laudicella R; Linguanti F; Nappi AG; Abenavoli E; Vergura V; Rubini G; Sciagrà R; Arnone G; Schillaci O; Minutoli F; Baldari S; Quartuccio N; Bisdas S
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
    Cronin P; Dwamena BA; Kelly AM; Carlos RC
    Radiology; 2008 Mar; 246(3):772-82. PubMed ID: 18235105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis.
    Woo S; Atun R; Ward ZJ; Scott AM; Hricak H; Vargas HA
    Eur Radiol; 2020 Oct; 30(10):5560-5577. PubMed ID: 32415584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas.
    Zikou A; Sioka C; Alexiou GA; Fotopoulos A; Voulgaris S; Argyropoulou MI
    Contrast Media Mol Imaging; 2018; 2018():6828396. PubMed ID: 30627060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentiation among Glioblastomas, Primary Cerebral Lymphomas, and Solitary Brain Metastases Using Diffusion-Weighted Imaging and Diffusion Tensor Imaging: A PRISMA-Compliant Meta-analysis.
    Zhang P; Liu B
    ACS Chem Neurosci; 2020 Feb; 11(3):477-483. PubMed ID: 31922391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The value of four imaging modalities to distinguish malignant from benign solitary pulmonary nodules: a study based on 73 cohorts incorporating 7956 individuals.
    Wu Q; Zhong L; Xie X
    Clin Transl Oncol; 2021 Feb; 23(2):296-310. PubMed ID: 32548796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and
    Qiao Z; Zhao X; Wang K; Zhang Y; Fan D; Yu T; Shen H; Chen Q; Ai L
    AJNR Am J Neuroradiol; 2019 Feb; 40(2):253-259. PubMed ID: 30655259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
    Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ
    Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
    Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
    J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy of
    Yu J; Zheng J; Xu W; Weng J; Gao L; Tao L; Liang F; Zhang J
    World Neurosurg; 2018 Jun; 114():e1211-e1224. PubMed ID: 29625311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
    Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
    Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma patients.
    Kim TH; Yun TJ; Park CK; Kim TM; Kim JH; Sohn CH; Won JK; Park SH; Kim IH; Choi SH
    Oncotarget; 2017 Mar; 8(12):20340-20353. PubMed ID: 27823971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors.
    Serizawa T; Saeki N; Higuchi Y; Ono J; Matsuda S; Sato M; Yanagisawa M; Iuchi T; Nagano O; Yamaura A
    J Neurosurg; 2005 Jan; 102 Suppl():266-71. PubMed ID: 15662823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.
    Sugahara T; Korogi Y; Tomiguchi S; Shigematsu Y; Ikushima I; Kira T; Liang L; Ushio Y; Takahashi M
    AJNR Am J Neuroradiol; 2000 May; 21(5):901-9. PubMed ID: 10815666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced multimodal imaging in differentiating glioma recurrence from post-radiotherapy changes.
    Li C; Gan Y; Chen H; Chen Y; Deng Y; Zhan W; Tan Q; Xie C; Sharma HS; Zhang Z
    Int Rev Neurobiol; 2020; 151():281-297. PubMed ID: 32448612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.